Browse by author
Lookup NU author(s): Dr Annette Neylon,
Professor Stephen O'Brien
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Until recently the therapeutic options available to patients diagnosed with chronic myeloid leukaemia hinged on their suitability for allogeneic bone marrow transplantation. With the advent of new agents targeting the specific molecular pathways involved in the disease, drug therapies may have an increasingly important role in improving outcome.
Author(s): Neylon A, O'Brien SG
Publication type: Article
Publication status: Published
Journal: Hospital Medicine
ISSN (print): 1462-3935
PubMed id: 11584615